Fresh analysis indicates that people who come off new slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who end conventional lifestyle regimens.
Findings released in a major health publication points out that while obese individuals can lose a large proportion of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users buying these medications must be informed of the danger of rapid rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery means a reversion to starting weight within about a year and a half.
Analyzing Therapies
The research, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Researchers emphasize that individuals who shed pounds through lifestyle changes alone usually experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Nutrition scientists suggest the way of the injections is key to understanding the amplified rebound.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone concentrations far above than normal may cause the system to produce less of its own natural hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making excessive eating much more probable."
An Ongoing Disease?
The NHS advise the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, due to the significant potential of relapse, the therapy is often ongoing.
This opinion is echoed by drug manufacturers, who say that the results "highlight the persistent character of excess weight," akin to managing conditions like high blood pressure.
Patient Testimonies
People who have come off the jabs report a powerful return of hunger.
"It felt as if something activating and you become starving," recalled one woman.
The struggle is compounded if users have not developed lasting dietary or behavioural modifications during treatment.
Significant Interest
Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is higher among women compared to males.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, experts caution that while the jabs are potent tools for shedding pounds, they are not a permanent fix and lasting health benefits relies on integrated behavioural support.
